Juvena Therapeutics develops biologic drug candidates by identifying and engineering human stem cell-secreted proteins into therapies that aim to restore tissue homeostasis and improve muscle and metabolic function. It uses a proprietary, AI-enabled discovery platform that maps the therapeutic potential of the secretome to disease phenotypes and advances selected proteins into engineered biologic medicines. The company’s pipeline includes engineered proteins for muscle regeneration and metabolic indications, with its lead candidate being evaluated in clinical studies for muscle-related disease. Juvena collaborates with partners to expand discovery efforts and explore new therapeutic targets using its computational and biological capabilities.